NEW YORK (GenomeWeb News) – Ocimum Biosolutions has landed an equity investment of up to $17 million and has closed its acquisition of Gene Logic’s genomics division, the company said today.
 
The capital investment came from Kubera Cross Border Fund, as well as affiliates of Kubera Partners, which manages KUBC.
 
Ocimum said that the acquired genomics business will retain the Gene Logic name and will continue operating out of Gaithersburg, Md.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.